Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.900 | strong | 0.915 | 1 | 0 | 1998 | 2020 | ||||||||
|
membrane metalloendopeptidase | 0.407 | 0.808 | 1.5E-18 |
|
disease | 0.300 | None | 0.955 | 1 | 0 | 2001 | 2020 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.300 | None | 0.978 | 1 | 0 | 1999 | 2019 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
disease | 0.300 | None | 0.923 | 1 | 0 | 2000 | 2019 | ||||||||
|
choline O-acetyltransferase | 0.520 | 0.808 | 5.6E-11 |
|
disease | 0.300 | None | 0.981 | 1 | 0 | 1987 | 2019 | ||||||||
|
C-C motif chemokine receptor 5 (gene/pseudogene) | 0.398 | 0.885 | 4.3E-10 |
|
disease | 0.240 | None | 0.800 | 1 | 0 | 2004 | 2019 | ||||||||
|
serpin family F member 1 | 0.460 | 0.846 | 7.8E-08 |
|
disease | 0.220 | None | 1.000 | 1 | 0 | 2006 | 2018 | ||||||||
|
heat shock protein family B (small) member 1 | 0.436 | 0.808 | 2.8E-07 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2011 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 1 | 0.460 | 0.885 | 6.2E-07 |
|
disease | 0.280 | None | 1.000 | 1 | 0 | 1997 | 2017 | ||||||||
|
glutathione-disulfide reductase | 0.494 | 0.846 | 1.3E-06 |
|
disease | 0.240 | None | 1.000 | 1 | 0 | 1998 | 2018 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
caspase 9 | 0.458 | 0.808 | 7.4E-06 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2000 | 2018 | ||||||||
|
metallothionein 2A | 0.553 | 0.808 | 1.2E-05 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
insulin receptor | 0.432 | 0.846 | 3.6E-05 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 2002 | 2020 | ||||||||
|
caspase 12 (gene/pseudogene) | 0.638 | 0.808 | 1.3E-04 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
calcium and integrin binding 1 | 0.458 | 0.769 | 3.3E-04 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2005 | 2017 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.700 | None | 0.946 | 2 | 0 | 1991 | 2020 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
disease | 0.300 | None | 0.981 | 1 | 0 | 2008 | 2020 | ||||||||
|
neuroglobin | 0.631 | 0.462 | 4.5E-03 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
microtubule associated protein tau | 0.446 | 0.923 | 6.0E-03 |
|
disease | 0.700 | None | 0.990 | 3 | 0 | 1988 | 2020 | ||||||||
|
insulin degrading enzyme | 0.604 | 0.577 | 6.6E-03 |
|
disease | 0.600 | None | 0.955 | 4 | 0 | 2000 | 2019 | ||||||||
|
insulin receptor substrate 1 | 0.488 | 0.769 | 2.4E-02 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
ADAM metallopeptidase domain 9 | 0.560 | 0.654 | 2.9E-02 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2011 | 2014 | ||||||||
|
S100 calcium binding protein B | 0.383 | 0.923 | 4.4E-02 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 1996 | 2019 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
disease | 0.570 | None | 1.000 | 1 | 0 | 2002 | 2019 |